Dongwha Pharm (000020)

Currency in KRW
4,970
-50(-1.00%)
Closed·
Advertisement
000020 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4,9505,090
52 wk Range
4,6957,140
Key Statistics
Bid/Ask
4,970.00 / 5,000.00
Prev. Close
4,970
Open
5,060
Day's Range
4,950-5,090
52 wk Range
4,695-7,140
Volume
50.06K
Average Volume (3m)
95.79K
1-Year Change
-27.2328%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
000020 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
15/05/2026
EPS / Forecast
361.47 / --
Revenue / Forecast
130.61B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 716.34%
Dividend Yield
1.29%
Industry Median 1.08%
Annualised payout
65.00
Paid annually
5-Years Growth
-
Growth Streak

Compare 000020 to Peers and Sector

Metrics to compare
000020
Peers
Sector
Relationship
P/E Ratio
7.4x7.6x−0.4x
PEG Ratio
0.010.070.00
Price/Book
0.4x0.6x2.6x
Price / LTM Sales
0.3x0.5x3.0x
Upside (Analyst Target)
-74.0%51.9%
Fair Value Upside
Unlock37.7%9.4%Unlock

Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.

Employees
826

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
401.62K1.45%2.02B
Other Institutional Investors
7.47M26.97%37.52B
Public Companies & Retail Investors
19.84M71.59%99.61B
Total
27.72M100.00%139.14B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dwp Holdings Corp.15.34%4,252,37021,346,897
Gha Song Foundation6.44%1,785,4258,962,834

FAQ

What Is the Dongwha Pharm (Seoul: 000020) Share Price Today?

The Dongwha Pharm stock price today is 4,970 KRW.

What Stock Exchange Does Dongwha Pharm (000020) Trade On?

Dongwha Pharm is listed and trades on the Seoul Stock Exchange.

What Is the Ticker (Stock Symbol) for Dongwha Pharm?

The stock symbol (also called a 'ticker') for Dongwha Pharm is "000020."

Does Dongwha Pharm Pay Dividends? What’s The Current 000020 Dividend Yield?

Yes, 000020 Pays Dividends to its Shareholders. The current Dongwha Pharm dividend yield is 1.31%.

What Is the Current Dongwha Pharm Market Capitalisation?

As of today, Dongwha Pharm (Seoul: 000020) market cap is 137.76B KRW.

What Is Dongwha Pharm's (000020) Earnings Per Share (TTM)?

The Dongwha Pharm EPS is currently 716 (Trailing Twelve Months).

When Is the Next Dongwha Pharm Earnings Date?

Dongwha Pharm's next earnings report will be released on 18/08/2026.

Is 000020 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Dongwha Pharm moving averages and other technical indicators, the daily buy/sell signal for 000020 stock is Strong Sell.

How Many Times Has Dongwha Pharm Stock Split?

Dongwha Pharm has split 3 times. (See the 000020 stock split history page for full effective split date and price information.)

How Many Employees Does Dongwha Pharm Have?

Dongwha Pharm has 826 employees, based on their latest Companies House report.

What is the current trading status of Dongwha Pharm (Seoul: 000020)?

As of 09/07/2026, Dongwha Pharm (000020) is trading at a share price of 4,970 KRW, with a previous close of 4,970 KRW. The stock has fluctuated within a day range of 4,950 KRW to 5,090 KRW, while its 52-week range spans from 4,695 KRW to 7,140 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.